Get started
Author

Sarah B. Thomson

Observed names: Sarah B Thomson, Thomson, Sarah Buckingham
ORCID: 0000-0001-9407-1245
Observed ORCID: 0000-0001-9407-1245
OpenAlex ID: A5028543373
The current landscape of nucleic acid therapeutics
2021 · Jayesh A. Kulkarni, Dominik Witzigmann, et al. · Nature Nanotechnology · 1,354
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
2022 · Pardis Kazemian, Si-Yue Yu, et al. · Molecular Pharmaceutics · 331
Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles
2020 · Jayesh A. Kulkarni, Sarah B. Thomson, et al. · Nanoscale · 72
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington’s disease mouse model
2022 · Sarah B Thomson, Anouk Stam, et al. · Brain · 27
PDF
Transcriptional Regulation of the Huntingtin Gene
2018 · Sarah B. Thomson, Blair R. Leavitt · Journal of Huntington s Disease · 22
PDF
Author Correction: The current landscape of nucleic acid therapeutics
2021 · Jayesh A. Kulkarni, Dominik Witzigmann, et al. · Nature Nanotechnology · 21
PDF
Restricting lysine normalizes toxic catabolites associated with ALDH7A1 deficiency in cells and mice
2024 · Amritpal S. Johal, Hilal H. Al-Shekaili, et al. · Cell Reports · 11
Computational Analysis of Transcriptional Regulation Sites at the HTT Gene Locus
2018 · Rebecca A.G. De Souza, Natalia Kosior, et al. · Journal of Huntington s Disease · 6
Humanized mice carrying a pathogenic GRN deletion as a pre-clinical platform for targeted gene therapies in frontotemporal dementia
2026 · Benjamin E. Life, Pardis Kazemian, et al. · Neurobiology of Disease · 1
Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing
2026 · Yi Lin Tay, Sarah B Thomson, et al. · Journal of Huntington s Disease · 1
PDF
Design and development of lipid nanoparticle formulations for brain gene therapy
2026 · Sarah B. Thomson, Alissandra de Moura Gomes, et al. · Molecular Therapy — Nucleic Acids
Works count: 12
Citation count: 1,846
H-index: 7
I10-index: 7
Year
Topic
Type